🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Love working with Journal for ImmunoTherapy of Cancer and delighted that it remains the #1 journal for immunotherapy of cancer both by impact factor and by number of publications.

Looking forward to the Immuno-Oncology 360° Summit, happening March 24-26, 2025, in Boston! #IO360Summit

Join the SITC Run Club for the 2025 AACR Runners for Research 5K Run/Walk in support of Cancer Research! do.nr/49dr11dl via DonorDrive @gulleyj1 Jennifer Guerriero, PhD

What an incredible group of people to work with! ⁦Society for Immunotherapy of Cancer⁩ ⁦Dr. Patrick Hwu⁩ ⁦Jennifer Guerriero, PhD⁩

Marengo Therapeutics is proud to announce that we received FDA Fast Track Designation for our First-in-Class Invikafusp Alfa (STAR0602) for treatment of unresectable, locally advanced, or metastatic colorectal cancers with high tumor mutational burden (TMB-H)

If you like learning about AI changing cancer care, listen to this episode from GovCIO Media & Research’s Cancer HealthCast about National Cancer Institute’s AI Resource program, which enables researchers to build AI models that help better detect and treat cancer through imaging. go.nih.gov/IJm4tB4

@gulleyj1 Zhen Su, MD; MBA Nick Tschernia, MD Annie Silk Claire Friedman MD Lillian Siu Guru P. Sonpavde, MD Marijo Bilusic, MD, PhD Society for Immunotherapy of Cancer National Cancer Institute Congratulations! OncoAlert @SassyCell Street Fights cancernetwork.com/view/invikafus…

#GI25 Is it the hardest to pronounce name of any antibody? Yes. It is also probably the best new treatment for GI malignancies? Also, probably yes. Daraxonrasib, pan-KRASi Amazing responses in second line PDAC Making the undruggable druggable. (Someone please teach me how to

Don't forget to join us tomorrow! #Bcells #TLS

3 consults this wk. PSA 1 or well below with no significant change. On ADT+ARPI, w/recommendation for chemo based on #PSMA “changes”. Rapidly discarding #ProstateCancer therapies likely is harming pts ⁦UroToday.com⁩ ⁦Journal of Clinical Oncology⁩ ⁦ASCO⁩ ascopubs.org/doi/10.1200/JC…

SITC (Society for Immunotherapy of Cancer) - The Advances in Cancer Immunotherapy oncodaily.com/blog/advances-… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews #Immunotherapy #GIcancers #BladderCancer

Share your research and discuss publication with Journal for ImmunoTherapy of Cancer Meet the Editor Session with Dr. Marcela V. Maus, co-Section Editor of the #JITC Immune Cell Therapies and Immune Cell Engineering section. Stop by the SITC booth (#2813) at #AACR25 from 12:30–1:30 p.m. CT on April 28.

Delighted to take a run in the Boston Commons this am. Skies still cloudy after the storm, but the sun will be out, I know it. ⁦Jennifer Guerriero, PhD⁩ ⁦Society for Immunotherapy of Cancer⁩